Clarify’s Medical Team exclusively utilizes technology from Lumenis, the inventor of IPL.
Lumenis OptiLIGHT (IPL) is the only IPL FDA–approved technology for the management of dry eye disease due to MGD.
OptiLIGHT elevates dry eye management with Lumenis’ patented Optimal Pulse Technology (OPT™) and user-centered design. Get the safe, precise, elegant procedure you want and the comfortable, effective therapy your patients need to manage dry eye disease with OptiLIGHT, a dry eye medical device.
Dry Eye Management with Lumenis OptiLIGHT (IPL) and Optimal Pulse Technology (OPT)
- Dry Eye Therapy
- Dry Eye Inflammation Reduction
- Dry Eye Gland Restoration – OptiPlus RF can improve gland structure and function by up to 70%.
Stop the vicious cycle of inflammation.
Reduce Inflammatory Mediators
Decrease the level of pro-inflammatory mediators to inhibit inflammation.
Improve Tear Breakup Time
Significantly boost tear break up time and decrease osmolarity.
Alleviate Abnormal Blood Vessels
- Destroy the abnormal blood vessels that perpetuate inflammation.
Restore Meibomian Glands
- Improve meibomian gland morphology and functionality.